Transcriptomics

Dataset Information

0

Novel MST1 inhibitor accelerates murine liver regeneration following partial hepatectomy with improved survival in models of steatohepatitis


ABSTRACT: Disrupted hepatocyte regeneration following surgical resection remains a clinical problem with few therapeutic options. The current treatment paradigm relies on supportive therapy until homeostasis can be achieved. Pharmacologic acceleration of regeneration may provide an alternative therapeutic avenue. Therefore, we aimed to generate a small molecule inhibitor that could accelerate liver regeneration in both normal and diseased murine preclinical models. mCLC846 demonstrated on target inhibition of MST1 and reduced EGFR inhibition which resulted in Yes-associated protein (YAP) activation. Oral delivery of mCLC846 perioperatively resulted in accelerated liver regeneration and improved survival in diet induced NASH models. Transcriptional analysis suggested that mCLC846 enhanced the normal regenerative pathways induced following liver resection. Overall, pharmacological acceleration of liver regeneration with mCLC846 was feasible, had an acceptable therapeutic index, and provided survival benefit in models of diet induced non-alcoholic steatohepatitis.

ORGANISM(S): Mus musculus

PROVIDER: GSE231391 | GEO | 2023/11/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-08-23 | E-GEOD-32510 | biostudies-arrayexpress
2010-04-07 | E-GEOD-12420 | biostudies-arrayexpress
2021-12-13 | GSE181935 | GEO
2014-08-23 | GSE32510 | GEO
2015-01-01 | E-GEOD-61582 | biostudies-arrayexpress
| PRJNA964752 | ENA
2015-01-01 | E-GEOD-61627 | biostudies-arrayexpress
2015-01-01 | GSE61582 | GEO
2020-04-29 | GSE138519 | GEO
2018-12-20 | GSE116033 | GEO